Home » Authors » Anette Breindl

Articles by Anette Breindl

Industry Studies High Quality, but Selective Publishing Problematic

Nov. 26, 2008

By Anette Breindl

Host Cell Components Promising Broad-Spectrum Antiviral Targets

Nov. 25, 2008

By Anette Breindl

New Method Cuts to the Chase in Protein Expression Profiling

Nov. 24, 2008

By Anette Breindl

New Stem Cell Type Shows Value of Sticking Together

Nov. 17, 2008

By Anette Breindl

New Research Links Tamoxifen Resistance to Her2 Expression

Nov. 13, 2008

By Anette Breindl

Improved T-Cell Receptor Takes on all Comers of HIV Epitope

Nov. 11, 2008

By Anette Breindl

Neural Repair: Studies Probe 'Complementary' Obstacles

Nov. 7, 2008

By Anette Breindl

Bacteria Cut Out the Middleman in Activating Clotting Cascade

Nov. 6, 2008

By Anette Breindl

Scientists Target Immune System Microenvironment to Strike Tumor

Nov. 4, 2008

By Anette Breindl

Composition of Gut Bacteria May Relate to Autoimmunity

Oct. 31, 2008

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...